Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Innovative Oncology Nurses Break Down Communication Barriers for Patients Who Are Deaf or Hard of Hearing
    Special Populations
    Innovative Oncology Nurses Break Down Communication Barriers for Patients Who Are Deaf or Hard of Hearing
    March 10, 2023
    How I Practice Mindfulness as an Oncology Nurse
    Nurse well-being
    How I Practice Mindfulness as an Oncology Nurse
    March 03, 2023
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    Oncology nurse education
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    January 13, 2023
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    Pancreatic cancer
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    November 11, 2022
    The Life of Marie Curie and Her Contributions to Oncology
    Cancer treatments
    The Life of Marie Curie and Her Contributions to Oncology
    November 07, 2022
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • ASCO Annual Meeting

    Psychological Distress Affects Caregivers but Not Patient Symptoms in Head and Neck Cancer

    Psychological stress in caregivers of patients with head and neck cancer (HNC) may impair the quality of patient care they provide and affect outcomes such as survival. However, patient symptom burden and caregiver tasks and their impact on psychological stress is not well understood.

    June 05, 2018
    ASCO Annual Meeting

    Using the Web for Oncology Training Curriculum

    Internet and web-based programs are becoming increasingly important resources in career training, including for oncology nursing. However, training in supportive oncology can still pose challenges. Researchers studied how institutions used web-based oncology training for healthcare professionals (HCPs) and presented their findings on Monday, June 4, at the 2018 American Society of Clinical Oncology Annual Meeting.

    June 04, 2018
    ASCO Annual Meeting

    Study Investigates How Health Literacy Affects Adherence to Oral Cancer Medications

    Ensuring patients adhere to oral medications for cancer can be a complex task, especially if patients have low health literacy. Oral medications for cancer continue to be more prevalent, but rates of adherence to oral therapy vary widely by population, cancer type, and level of education. At the 2018 American Society of Clinical Oncology Annual Meeting, researchers presented the results of a study that hypothesized health literacy’s connection to oral medication adherence and whether a multilevel intervention approach would result in greater adherence.

    June 04, 2018
    ASCO Annual Meeting

    Team-Based Professional Development Improves Knowledge Gap for Oncology Geriatric Care

    Oncology nurses often work with older patients with cancer, but knowledge gaps in training can remain. To combat this issue, researchers implemented an educational curriculum in geriatric care for oncology nurses and presented the results of that training at the 2018 American Society of Clinical Oncology Annual Meeting.

    June 03, 2018
    ASCO Annual Meeting

    Researchers Clarify Connection Between Night Shift Work Duration and the Risk of Colorectal Cancer

    Evidence already supports a connection between night shift work and an increased risk of colorectal cancer (CRC), but the mechanism has been difficult to pinpoint. In a study presented at the 2018 American Society of Clinical Oncology Annual Meeting, researchers evaluated the insulin receptor substrate (IRS) 1 and 2 proteins and presented the role they play in the connection of night shift work and CRC.

    June 03, 2018
    ASCO Annual Meeting

    Study Gives a Better Understanding of ARID1A Mutations in Colorectal Cancer

    A component of the SWI/SNF chromatin remodeling complex, AT-rich interactive domain 1A (ARID1A), regulates gene expression. Data on the characteristics and associated clinicopathologic features of ARID1A in colorectal cancer (CRC) are limited, even though its mutations are reported in a variety of other cancers. In study findings presented at the 2018 American Society of Clinical Oncology Annual Meeting, researchers explained an increased understanding of the ARID1A mutation in CRC.

    June 03, 2018
    ASCO Annual Meeting

    Early Oncology Care Model Data Show Reduced Hospital Admissions

    Improving quality and reducing costs in a practice are two of the Oncology Care Model’s (OCM) key goals, and one of the best ways to achieve them is to reduce unnecessary emergency department (ED) visits and hospitalizations. During a study presented at the 2018 American Society of Clinical Oncology Annual Meeting, researchers described a campaign implemented to reach those objectives.

    June 02, 2018
    ASCO Annual Meeting

    Patients Report More Satisfaction With Multidisciplinary Care Versus Serial Care for Lung Cancer

    Despite the prevalence of multidisciplinary (MD) care for cancer, rigorous studies comparing it to serial care (SC) are lacking. To address the literature gap, researchers explored the use of MD versus SC for lung cancer and presented the findings at the 2018 American Society of Clinical Oncology Annual Meeting.

    June 02, 2018
    Study Finds That Safety Decreases as Electronic Health Record Capability Increases
    ASCO Annual Meeting

    Study Finds That Safety Decreases as Electronic Health Record Capability Increases

    More needs to be known about how communication challenges and documentation affect ambulatory oncology care. In a presentation on Saturday, June 2, at the 2018 American Society of Clinical Oncology Annual Meeting, researchers revealed study findings about how patient safety is directly affected by electronic health record (EHR) capability and satisfaction, clinician communication, and clinicians’ actions.

    June 02, 2018
    ASCO Annual Meeting

    What’s the Rate of Depression and Anxiety in Oncology Nurses?

    The oncology nursing profession is a difficult career, fraught with long hours and stressful situations. With those factors, anxiety and depression could become more prevalent. In study findings published in conjunction with the 2018 American Society of Clinical Oncology Annual Meeting, researchers reported the rates of depression and anxiety among nurses working in oncology units and how certain situations related to these rates.

    May 29, 2018
    ASCO Annual Meeting

    Nurses Should Focus on Goal Setting and Shared Decision Making in Cancer Aftercare Conversations

    Goal setting and shared decision making are important components of aftercare for cancer survivors. In the results of a study published in conjunction with the 2018 American Society of Clinical Oncology Annual Meeting, researchers shared their experience developing and pretesting a systematic conversation approach for nurses to tailor the aftercare needs and goals of cancer survivors.

    May 29, 2018
    ASCO Annual Meeting

    Organizational Learning and Perception Tied to Improved Patient Safety Culture

    Patient safety is an important focus for hospitals: protecting patients improves outcomes and quality of care, meets standards, and ensures payments and reimbursement. But what factors contribute to a culture of safety? Researchers assessed and analyzed the components of patient safety culture and published their study findings in conjunction with the 2018 American Society of Clinical Oncology Annual Meeting.

    May 29, 2018
    ASCO Annual Meeting

    Study Quantifies Data on NPs and PAs Caring for Older Adults With Cancer

    Cancer is the most common diagnosis in adults older than 65 in the United States. As the older adult population increases and drives up malignancy diagnoses, nurse practitioners’ (NPs) and physician assistants’ (PAs) contributions to their care need to be better identified. In the results of a study published in conjunction with the 2018 American Society of Clinical Oncology Annual Meeting, researchers reported on their exploration of the role of NPs and PAs in the oncology workforce.

    May 29, 2018
    ASCO Annual Meeting

    Adverse Events Influence Patient-Reported Quality-of-Life Scores

    Researchers conducted a single-center, cross-sectional study to examine the relationship between patient-reported quality-of-life (QOL), adverse events (AEs), and treatment characteristics (including tumor type, drug class, number of cycles, and treatment intent). The study’s findings were presented at the 2017 ASCO Annual Meeting.

    June 05, 2017
    ASCO Annual Meeting

    Patient-Provider Communication on Immunotherapy Can Be Improved

    Guidelines regarding healthcare provider communication about immunotherapy do not currently exist. Researchers sought to determine patient and provider preferences for this type of information and to identify barriers to communication about immunotherapy. The study’s findings were presented at the 2017 ASCO Annual Meeting.

    June 05, 2017
    ASCO Annual Meeting

    Discussion About Goals of Care May Improve Patient Understanding

    Discussing goals of care with patients with advanced cancer can provide better information on the disease, treatment options, and prognosis, as well as elicit patient values. A randomized, controlled trial tested a coaching model to improve healthcare providers’ communication on goals of care. The study’s findings were presented at the 2017 ASCO Annual Meeting.

    June 05, 2017
    ASCO Annual Meeting

    Chemotherapy Use Near the End of Life Is More Common in United States

    National guidelines suggest that the use of chemotherapy near end of life (EOL) is aggressive and is associated with poorer patient quality of life. In addition, Medicare payments for outpatient chemotherapy have decreased since around 2005–2006. In a recent study presented at the 2017 ASCO Annual Meeting, researchers evaluated the impact of U.S. payment reform and guidelines on chemotherapy use at EOL, comparing chemotherapy use at EOL in the United States and other countries.

    June 05, 2017
    ASCO Annual Meeting

    Patients Are Equally Satisfied With Phone Calls and In-Person Consultations Before Chemotherapy

    Previous research has indicated that patient satisfaction is linked to time spent with a physician. However, long wait times and organizational issues in an outpatient setting may increase the need for alternative care models. In a study presented at the ASCO Annual Meeting, researchers assessed the use of phone calls instead of a face-to-face consultation prior to chemotherapy (CT) and the effect on patient satisfaction and quality of life.

    June 05, 2017
    ASCO Annual Meeting

    Researchers Identify Factors Associated With Readmission for Patients With Metastatic Cancer

    Hospital readmission rates may be avoidable in some patients with metastatic disease. Researchers assessed patient factors more likely to be associated with increased readmissions, such as demographics, comorbidities, hospital type, payer, and discharge disposition, in a study presented at the ASCO Annual Meeting.

    June 05, 2017
    ASCO Annual Meeting

    Location of Discharge Affects Quality of Life and Symptom Burden for Those With Advanced Cancer

    Patients with advanced-stage cancer experience frequent hospitalizations, followed by post-discharge transitions of care that can influence patient quality of life. A study presented at the ASCO Annual Meeting sought to examine predictors of discharge location for these patients.

    June 05, 2017
    ASCO Annual Meeting

    Cancer Screening Protocol Improves Morbidity and Mortality

    Long-term (10-year) follow-up of a cancer screening tool indicated more early cancer diagnoses, according to a study presented at the ASCO Annual Meeting.

    June 05, 2017
    ASCO Annual Meeting

    Genetic Screening Tool Identifies Women With BRCA Mutations Who May Have Been Otherwise Missed

    Researchers sought to assess the value of breast imaging centers (BICs) as potential clinics to identify women who are at high risk for hereditary breast and ovarian cancer (HBOC) and increase the number of appropriate referrals for genetic assessment. The researchers’ hospital-based BIC serves mostly low- to middle-income patients in a major metropolitan area. They developed a practical screening tool based on the National Comprehensive Cancer Network HBOC screening and testing guidelines and prospectively screened patients. The researchers presented their findings at the ASCO Annual Meeting.

    June 05, 2017
    ASCO Annual Meeting

    Patient-Reported Tool to Evaluate Distress Predicts Survival

    The Living With Cancer (LWC) patient-reported outcome (PRO) tool evaluates distress in patients with advanced cancer using a seven-item Likert survey to measure performance status, pain, burden (financial and family), and depression, with scores ranging from 0–112.

    June 03, 2017
    ASCO Annual Meeting

    Up-Front Palliative Care Consultation Associated With Better Outcomes in Advanced Cancer

    Optimal timing for the initiation of specialist palliative care has not been determined. In a study, researchers created a supportive oncology inpatient service that integrates up-front palliative care consultation for certain patients with advanced cancer and compared it to those receiving usual oncologic care with on-demand palliative care consultation. The study’s findings were presented at the ASCO Annual Meeting.

    June 03, 2017
    ASCO Annual Meeting

    Occupational and Physical Therapy May Improve Mental Health for Older Adults With Cancer

    Older adults with cancer can have limited functional and health status; however, occupational (OT) and physical therapy (PT) are underused resources of care in this patient population. Researchers evaluated an outpatient CAncer REhabilitation (CARE) intervention program for this older adults in comparison to usual care. The study’s findings were presented at the ASCO Annual Meeting.

    June 03, 2017
    ASCO Annual Meeting

    Study Assesses Response to Pembrolizumab Based on Biomarkers in Patients With Soft Tissue or Bone Sarcomas

    The multicenter, phase II SAR028 clinical trial was the first to study pembrolizumab monotherapy in patients with soft tissue sarcoma or bone sarcoma to assess the clinical efficacy signals in multiple histologies. The researchers presented extended follow-up data at the ASCO Annual Meeting.

    June 02, 2017
    ASCO Annual Meeting

    Integrated Palliative Care Following HCT Improves Some Psychologic Outcomes

    Hospitalization following hematopoietic cell transplantation (HCT) can lead to significant psychologic distress for patients. Researchers assessed the impact of an inpatient palliative care intervention on patient reported quality-of-life (QOL), mood, and post-traumatic stress disorder (PTSD) six months post-HCT. The researchers presented the study at the ASCO Annual Meeting.

    June 02, 2017
    ASCO Annual Meeting

    Olaparib Does Not Decrease Quality-of-Life in Patients With Ovarian Cancer

    Patients with platinum-sensitive relapsed (PSR) serous ovarian cancer (SOC) have poor survival outcomes, with the median progression-free survival (PFS) after chemotherapy less than six months in many patients. Based on results from the SOLO2 study that found that maintenance olaparib after response to chemotherapy resulted in a significant improvement in PFS compared to placebo (median PFS = 19.1 versus 5.5 months) in patients with germline BRCA mutation PSR SOC (hazard ratio [HR] = 0.30; 95% CI = 0.22–0.41; p < 0.0001), researchers assessed the impact of health-related quality-of-life (HRQOL). The researchers presented the study at the ASCO Annual Meeting.

    June 02, 2017
    ASCO Annual Meeting

    Adherence to Nutritional and Physical Activity Guidelines Improves Survival in Patients With Colon Cancer

    The American Cancer Society (ACS) has guidelines on nutrition and physical activity for cancer survivors that focus on healthy body weight, physical activity, and a diet high in vegetables, fruits, and whole grains. To assess how adherence to those guidelines impacts disease-free survival (DFS), relapse-free survival (RFS), or overall survival (OS), researchers conducted a prospective study of 992 patients with stage III colon cancer who enrolled in an adjuvant chemotherapy clinical trial between 1991 and 2001. The researchers presented the study at the ASCO Annual Meeting.

    June 02, 2017
    ASCO Annual Meeting

    Chemotherapy Plus Radiotherapy Not Superior to Radiotherapy Alone in Improving Survival for Patients With High-Risk Endometrial Cancer

    Women with high-risk endometrial cancer (EC) are at an increased risk of metastasis and death. The randomized, intergroup PORTEC-3 study assessed the benefit of adjuvant chemotherapy during and after radiotherapy (RT) versus pelvic RT alone in this patient population. The researchers presented the study at the ASCO Annual Meeting.

    June 02, 2017
    ASCO Annual Meeting

    NCI Tool Helps Clinicians Collect Patient-Reported Outcomes and Adverse Event Information

    During a session presented at the 2016 ASCO Annual Meeting that discussed the benefits and challenges of assessing patient-reported outcomes (PROs) in the era of precision medicine and the integration of PROs into clinical trial data and regulatory reviews, ONS member Sandra A. Mitchell, PhD, CRNP, from the National Cancer Institute (NCI), presented the NCI’s PRO version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) measurement system.
    June 07, 2016
    ASCO Annual Meeting

    Incorporating Advanced Practitioners Into Team-Based Oncology Care

    During a session presented at the 2016 ASCO Annual Meeting that discussed team-based oncology care, ONS member Wendy H. Vogel, MSN, FNP, AOCNP®, an oncology nurse practitioner at Wellmont Cancer Institute in Kingsport, TN, discussed how advanced practice providers can be involved in the care team process.
    June 06, 2016
    ASCO Annual Meeting

    Vaccine for Metastatic Melanoma Demonstrates Encouraging Five-Year Overall Survival

    In previous studies of CLBS20—a patient-specific therapeutic vaccine consisting of autologous dendritic cells loaded with antigens from irradiated cells from an autologous tumor cell line—the vaccine was associated with a 72% two-year overall survival (OS), with the most common toxicities including mild local injection site reactions. A recent study provided long-term survival data for patients treated with CLBS20. The researchers presented the study at the ASCO Annual Meeting.
    June 06, 2016
    ASCO Annual Meeting

    RN-Led Disease Management Intervention Decreases Time to Treatment for Veterans With Cancer

    In 2008, a disease management program was initiated at the Hudson Valley Veterans Health Care System in Montrose, NY, in an effort to decrease time to diagnosis and/or treatment for veterans with newly diagnosed cancer. Administrators at the health system chose the disease case management team model as a potentially useful solution to enhance and expedite healthcare delivery for this patient population. The researchers presented the study at the 2016 ASCO Annual Meeting.
    June 06, 2016
    ASCO Annual Meeting

    Improve Management of Common Symptoms for Breast Cancer Survivors

    During a session presented at the 2016 ASCO Annual Meeting exploring breast cancer survivorship, ONS member Debra L. Barton, RN, PhD, AOCN®, FAAN, a professor at the University of Michigan, discussed how effective management of symptoms can improve rates of adherence to therapy.
    June 06, 2016
    ASCO Annual Meeting

    Analysis Finds Nurse Practitioner-Led Survivorship Programs Adhere to IOM Guidelines for Care

    A variety of survivorship care models have been developed internationally, but data comparing the different plans are limited. A retrospective analysis assessed the concordance of care plans for adult cancer survivors in nurse practitioner (NP)-led clinics with Institute of Medicine (IOM) guidelines for comprehensive survivorship care. The researchers presented the study at the ASCO Annual Meeting.
    June 06, 2016
    ASCO Annual Meeting

    Colonoscopy Screening Is Beneficial for Older Medicare Beneficiaries

    Since 2001, Medicare has allowed reimbursement for colonoscopy screenings with no maximum patient age. A large-scale, population-based study used data from Medicare beneficiaries to evaluate the effectiveness of colonoscopy screening to prevent colorectal cancer (CRC) in patients aged 70 years or older. The researchers presented the study at the ASCO Annual Meeting.
    June 06, 2016
    ASCO Annual Meeting

    Study Examines Increase in FDA-Approved Oncology Drugs in the Past Five Years

    The U.S. Food and Drug Administration (FDA) approved the most novel oncology drugs in 2015 compared with the past 19 years. Researchers evaluated factors associated with the significant increase in FDA-approved oncology agents over the past five years. The researchers presented the study at the ASCO Annual Meeting.
    June 06, 2016
    ASCO Annual Meeting

    Patients Overestimate Recurrence Risk After Breast Cancer

    With limited data on the patterns and correlations of recurrence risk in patients with breast cancer, a study explored numeric and descriptive patient risk perception in a large population of patients with breast cancer who had favorable prognosis to assess associations between overestimation and quality of life (QOL). The researchers presented the study at the ASCO Annual Meeting.
    June 04, 2016
    ASCO Annual Meeting

    Intervention Aims to Reduce Racial Mortality Inequality for Patients With Treatable Lung and Breast Cancers

    Previous research has indicated that African American patients with potentially curable lung or breast cancer are less likely to receive or complete standard treatments compared with Caucasian patients, which leads to inequalities in racial mortality rates. The Accountability for Cancer Care Through Undoing Racism and Equity Study examined systematic changes to reduced treatment disparities in cancer care. The researchers presented the study at the ASCO Annual Meeting.
    June 04, 2016
    ASCO Annual Meeting

    Oncology Nurses Can Improve Oral Medication Management With Patient Education Program

    The prescription of oral oncology therapies has increased over time thanks to the clinical benefits; however, the inadequate use of these drugs can lead to ineffectiveness and early discontinuation of therapy. Oral therapy also places a self-management burden on the patient and requires a competent understanding of treatment. A study evaluated the implementation of a nurse-led patient education program to influence the handling of oral agents. The researchers presented the study at the ASCO Annual Meeting.
    June 04, 2016
    ASCO Annual Meeting

    Supportive Care Is Underused for Younger Patients With Cancer at End-of-Life

    A study examined the impact of ASCO’s 2012 Choosing Wisely campaign that promotes reducing the overuse of aggressive end-of-life care and opting for increased supportive care services, such as hospice, home health nursing, and palliative care consultations.
    June 04, 2016
    ASCO Annual Meeting

    Address Depression in Patients With Metastatic Disease

    Patients who are diagnosed with cancer can experience depression, which is associated with poor health behavior and overall prognosis. A cross-sectional study sought to examine sociodemographic and clinical factors that might predict depression in patients with metastatic tumor. The researchers presented the study at the ASCO Annual Meeting.
    June 04, 2016
    ASCO Annual Meeting

    Large Study Examines the Extent of Treatment-Related Adverse Events

    Many studies focus on treatment-related toxicities, but limited data are available on the frequency, spectrum, and preventability of adverse events (AEs) across cancer care. The retrospective, cohort CHARM (Cancer Harm) study conducted manual reviews of medical records and reports from local databases to assess the nature and extent of AEs in patients with cancer. The researchers presented the study at the ASCO Annual Meeting.
    June 04, 2016
    ASCO Annual Meeting

    Nurse-Led Patient Navigation Program Improves Cancer Survival

    Patient navigation programs can help to improve outcomes and reduce disparities; however, little is known about their effects on clinical outcomes, such as survival. In a retrospective, cohort study, a nurse-led patient navigation program was initiated to assess 12-month survival outcomes. The researchers presented the study at the ASCO Annual Meeting.
    June 04, 2016
    ASCO Annual Meeting

    Palbociclib Plus Fulvestrant Provides Benefit for Patients With HR+ Metastatic Breast Cancer

    Previous studies have demonstrated that ESR1 mu is a mechanism for acquired endocrine resistance in metastatic breast cancer (mBC). The randomized, double-blind, phase III PALOMA-3 study compared the use of palbociclib plus fulvestrant (P+F) versus fulvestrant plus placebo (F+Pla) in pre- and postmenopausal women with hormone receptor positive (HR+)/hormone estrogen receptor 2 negative mBC who have progressed on prior endocrine therapy. The researchers presented the study at the ASCO Annual Meeting.
    June 03, 2016
    ASCO Annual Meeting

    Study Examines Treatment With Abemaciclib for HR+/HER2− Metastatic Breast Cancer

    Abemaciclib—an oral, selective inhibitor of CDK4 and CDK6—demonstrated single-agent activity in a phase I trial of patients with refractory hormone-receptor positive (HR+) metastatic breast cancer (mBC), with some tumor responses occurring after at least 8 months of treatment. The phase II, single-arm MONARCH1 study evaluated the safety and efficacy of abemaciclib monotherapy in women with HR+/hormone estrogen receptor 2 negative (HER2−) mBC who have progressed on or after endocrine therapy and chemotherapy. The researchers presented the study at the ASCO Annual Meeting.
    June 03, 2016
    ASCO Annual Meeting

    ESR1 Mutation Reduces Overall Survival for HR+ Metastatic Breast Cancer

    Somatic and circulating activating ESR1 mutations have been shown to be related to aromatase inhibitor (AI) resistance in hormone receptor positive (HR+) metastatic breast cancer (mBC). In a monocentric, retrospective analysis, researchers sought to evaluate the predictive and prognostic values of circulating ESR1 mutation detection at time of disease progression in patients with mBC receiving AI treatment. The researchers presented the study at the ASCO Annual Meeting.
    June 03, 2016
    ASCO Annual Meeting

    Year of Treatment May Predict Subsequent Neoplasm Risk Among Childhood Cancer Survivors

    For childhood cancer survivors, limited data are available on whether historical changes in therapeutic exposure have altered subsequent neoplasm (SN) risk. Researchers used the Childhood Cancer Survivor Study to evaluate the occurrence of SNs in 23,603 survivors who were diagnosed earlier than 21 years of age and have reached five years of survival. The researchers presented the study at the ASCO Annual Meeting.
    June 03, 2016
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲